|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Loss (income) from discontinued operations | |||||
| Income from continuing operations | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Stock-based compensation | |||||
| Amortization and impairments to operating lease assets | |||||
| Depreciation | |||||
| Amortization of acquired intangible assets | |||||
| Amortization and write-off of debt discount and issuance costs | |||||
| Provision for credit losses | |||||
| Deferred income taxes | |||||
| Gain on extinguishment of debt | |||||
| Loss on disposals and impairments of property and equipment | |||||
| Gain on investments | |||||
| Gain on sale of assets | |||||
| Loss on assets held for sale | |||||
| Changes in assets and liabilities: | |||||
| Accounts and financing receivables | |||||
| Prepaid expenses and other current assets | |||||
| Cloud computing implementation assets | |||||
| Accounts payable | |||||
| Accrued payroll and benefits | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities-continuing operations | |||||
| Net cash provided by operating activities-discontinued operations | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sales of marketable securities | |||||
| Purchases of marketable securities | |||||
| Payment for investment in business | |||||
| Proceeds from note receivable related to property sold | |||||
| DeVry University | |||||
| Total proceeds from note receivable related to property sold | |||||
| Payment for purchase of business, net of cash and restricted cash acquired | |||||
| Net cash (used in) provided by investing activities-continuing operations | |||||
| Net cash used in investing activities-discontinued operations | |||||
| Proceeds from sale of business, net of cash transferred | |||||
| Payment for working capital adjustment for sale of business | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Employee taxes paid on withholding shares | |||||
| Proceeds from stock issued under Colleague Stock Purchase Plan | |||||
| Repurchases of common stock for treasury | |||||
| Payment on equity forward contract | |||||
| Borrowings under long-term debt obligations | |||||
| Repayments under long-term debt obligations | |||||
| Payment of debt discount and issuance costs | |||||
| Payment for purchase of redeemable noncontrolling interest of subsidiary | |||||
| Payment of debt issuance and extinguishment costs | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow disclosure: | |||||
| Interest paid | |||||
| Income taxes paid, net | |||||
| Non-cash investing and financing activities: | |||||
| Accrued capital expenditures | |||||
| Accrued liability for repurchases of common stock | |||||
| Settlement of financing liability with assets | |||||
| Accrued excise tax on share repurchases | |||||
Loading...